Latest Non-small cell lung carcinoma Stories
Alexander Chi, MD, a thoracic radiation oncologist at West Virginia University, is the principal investigator in the study of novel treatment approaches for non-small cell lung cancer.
SAN DIEGO, March 25, 2015 /PRNewswire/ -- Agena Bioscience today released the LungFUSION Panel for rapid and sensitive identification of oncogenic ALK, RET, and ROS1
Close competition encourages established manufacturers to broaden the drug pipeline for targeted therapies, finds Frost & Sullivan LONDON, March 3, 2015 /PRNewswire/ -- Although lung
BOTHELL, Wash. and VANCOUVER, British Columbia, Feb. 24, 2015 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc.
A new study from the RSSearch® Patient Registry, the largest patient registry dedicated to radiosurgery and stereotactic body radiotherapy (SBRT), describes treatment management practices
TUCSON, Ariz., Jan. 21, 2015 /PRNewswire/ -- Ventana Medical Systems, Inc.
Company expands lung cancer clinical program for its Precision Cancer MonitoringSM solution to up to 700 patients at three leading cancer centers SAN DIEGO, Jan.
- Results from two large trials individually showed an improvement in the secondary endpoint of overall survival for patients with the most common EGFR mutation (Del19) RIDGEFIELD, Conn., Jan.
The Oncology Institute of Hope and Innovation announces first clinical trial of the year. Downey, CA (PRWEB) January 10, 2015 The Oncology Institute
- Discuss interim results for Study 202 evaluating PEGPH20 with gemcitabine and ABRAXANE® in pancreatic cancer patients - SAN DIEGO, Jan.
- Large; stout; burly.